Search
-
NewJosep Samitier: "It's key to strengthen public private collaboration and attract venture ...
Josep Samitier, a leading figure in bioengineering and nanomedicine, reflects on the key milestones of his time at the helm of IBEC and discusses the challenges facing the biotech ecosystem in Spain
-
NewORYZON strengthens vafidemstat patent portfolio with U.S. Notice of Allowance
Covers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality Disorder (BPD).
-
NewAptadel Therapeutics raises 2 million euros and prepares a new round to bring the projec...
Aptadel Therapeutics advances in its treatment for Ewing's sarcoma after closing a bridge round of 2 million euros.
-
NewMTBVAC moves toward its final stage: the vaccine candidate that could mark a turning point...
According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants.
-
NewORYZON announces U.S. patent grant covering iadademstat combinations with venetoclax
Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in combination with venetoclax and azacitidine.
-
NewGSK opens Spain’s first maximum biosecurity laboratory
Spain Prime Minister, Pedro Sánchez, recently visited the first maximum biosafety level (BSL-4) laboratory in Spain, located in Tres Cantos (Madrid). It is the world's only facility of its kind
-
NewAseBio promotes in Brussels the vision of the Spanish biotechnology sector on the Biotech ...
Our Director General, Ion Arocena, participated in the latest meeting of the MEP Interest Group “EU Biotech and Life Sciences Alliance” with the aim of bringing clarity and guidance to the European
-
NewYsios Capital appoints Joan Perelló as Managing Partner and Arturo Urrios as Partner to d...
Joan Perelló and Arturo Urrios will lead a new vertical focused on company creation and early-stage biotech projects, with a strong focus on Spain.
-
New#NewAseBioMember | "AseBio is the main meeting point for the biotechnology sector in Spain...
Meet Arquea Biological Innovations, our new member. We spoke with Fernando Garcia Osorio, CEO.
-
New#NewAseBioMember | “AseBio represents credibility, sector cohesion, and a unified voice”
Meet Macami Biotech, our new member. We spoke with Miguel Rodríguez-Villa Förster, CEO.
-
NewPromising results for GAT Therapeutics drug in development for pulmonary fibrosis
The biotech company GAT Therapeutics, based at the University of Barcelona Parc Científic de Barcelona (PCB-UB), is making progress in the development of GTX-11, a new oral drug candidate for the
-
NewGENESIS Biomed sponsors the 4th Conference on Healthcare Entrepreneurship at the Gregorio ...
The conference was organised by the UAI (Innovation Support Unit) of the IiSGM (Gregorio Marañón Health Research Institute) and was sponsored by GENESIS Biomed, HOFFMANN EITLE, DINAMIZA Health
-
NewORYZON expands patent protection for iadademstat with grant decision in Mexico covering co...
Key combination for the treatment of Small Cell Lung Cancer.
-
NewGreen Innovation Forum: Salamanca as a meeting point for startups, researchers, and invest...
We interviewed Pedro Martínez, Councilor for Economic Promotion at the Salamanca City Council, to learn about the potential of its ecosystem and the opportunities the Green Innovation Forum offers for
-
New#NewAseBioMember “AseBio for us, it is the strategic meeting point where biotechnology con...
Meet Phoenix Biosolutions, our new member. We spoke with Carlos Rodríguez-Villa Förster, CEO.
-
NewDiana Morant, Minister for Science, Innovation and Universities: “Biotechnology is a strat...
The Spanish Bioindustry Association (AseBio) has organized a conference at the Ministry of Science that brought together leading institutional, political, and industry stakeholders to present a
-
NewIllumina launches TruPath Genome, setting a new standard in genomic insight
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow. Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease. Broad
-
NewSequencing to diagnose earlier: how biotechnology can help short the rare diseases diagnos...
In a context in which most of these pathologies have a genetic origin, tools such as whole genome sequencing (WGS) are set to transform diagnosis and clinical practice, shortening times and improving
-
-
New#NewAseBioMember | “AseBio is the meeting point and the voice of the biotech sector in Spa...
Meet ELE Biotech, our new member. We spoke with Laura Vallés Saiz and Elena Calvo Cantero, CEO and co-founder, and COO and also co-founder, respectively.
-
NewMore than 60% of biotech R&D staff are women, who represent 29% of management teams
Globally, fewer than 30% of researchers are women, indicating that female talent is still not fully integrated into research and innovation.